Basel Medical Group Ltd (NASDAQ:BMGL) Sees Large Decline in Short Interest

Basel Medical Group Ltd (NASDAQ:BMGLGet Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totaling 24,576 shares, a decline of 77.7% from the April 30th total of 110,046 shares. Based on an average trading volume of 31,239 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on Basel Medical Group

Basel Medical Group Trading Up 1.6%

Basel Medical Group stock traded up $0.01 during mid-day trading on Friday, hitting $0.59. The company had a trading volume of 16,961 shares, compared to its average volume of 21,740. The stock’s 50 day moving average price is $0.63 and its two-hundred day moving average price is $0.73. Basel Medical Group has a 12 month low of $0.49 and a 12 month high of $9.40.

Institutional Investors Weigh In On Basel Medical Group

Several hedge funds have recently added to or reduced their stakes in the stock. Marex Group plc purchased a new position in shares of Basel Medical Group in the second quarter worth $25,000. Vanguard Personalized Indexing Management LLC purchased a new position in shares of Basel Medical Group in the third quarter worth $40,000. Virtu Financial LLC raised its stake in shares of Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after purchasing an additional 17,608 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new position in shares of Basel Medical Group in the third quarter worth $169,000.

Basel Medical Group Company Profile

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

See Also

Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.